Advertisement

Topics

PubMed Journal Database | Nature biotechnology RSS

11:15 EDT 26th April 2018 | BioPortfolio

The US National Library of Medicine and National Institutes of Health manage PubMed.gov which comprises of more than 21 million records, papers, reports for biomedical literature, including MEDLINE, life science and medical journals, articles, reviews, reports and  books.  BioPortfolio aims to publish relevant information on published papers, clinical trials and news associated with users selected topics.

For example view all recent relevant publications on Epigenetics and associated publications and clincial trials.

Showing PubMed Articles 1–25 of 1,000+ from Nature biotechnology

Gender differences in obtaining and maintaining patent rights.

The long view on sequencing.

Recent patents in tumor detection and treatment.

Epigenome editing to the rescue.

Rollout of high-priced cell and gene therapies forces payer rethink.

Low-molecular-weight albumin drug touted for severe osteoarthritis.

Nature Biotechnology's academic spinouts of 2017.

Portable gene expression guaranteed.

Patching the retina with stem cells.

New drug for multidrug-resistant HIV.

Metabolomics activity screening for identifying metabolites that modulate phenotype.

Metabolomics, in which small-molecule metabolites (the metabolome) are identified and quantified, is broadly acknowledged to be the omics discipline that is closest to the phenotype. Although appreciated for its role in biomarker discovery programs, metabolomics can also be used to identify metabolites that could alter a cell's or an organism's phenotype. Metabolomics activity screening (MAS) as described here integrates metabolomics data with metabolic pathways and systems biology information, including pr...

Around the world in a month.

Critics say 'right to try' wrong for patients.

Roche pays $1.9 billion for Flatiron's army of electronic health record curators.

FDA approves stroke-detecting AI software.

Involving undergraduates in genomics research to narrow the education-research gap.

Migraine drug race turns its final corner, FDA decisions in sight.

First off-the-shelf mesenchymal stem cell therapy nears European approval.

First Rounders podcast: Jeffrey Leiden.

Jury out on liquid biopsies for cancer.

Around the world in a month.

Evidence for a mental health crisis in graduate education.

Preprint wipes millions off CRISPR companies' stocks.

EPO revokes Broad's CRISPR patent.

Amazon's cloud on the healthcare horizon.


Advertisement
Quick Search
Advertisement
Advertisement